David Scadden - Director at Dianthus Therapeutics, Inc. /DE/

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
DNTH on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David Scadden since 7/7/2023

Holdings reported by David Scadden for Dianthus Therapeutics, Inc. /DE/

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 20,000 Jun 28, 2022 Direct Common Stock

Transactions reported by David Scadden for Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership